Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites

Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites

A risk score for atrial fibrillation (AF) has been developed by the Framingham Heart Study and Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)-AF consortium. However, validation of these risk scores in an inner-city population is uncertain. Thus, a validation model was built us...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2016-01, Vol.117 (1), p.76-83
Hauptverfasser: Shulman, Eric, MD, Kargoli, Faraj, MD, MPH, Aagaard, Philip, MD, PhD, Hoch, Ethan, BS, Di Biase, Luigi, MD, PhD, Fisher, John, MD, Gross, Jay, MD, Kim, Soo, MD, Krumerman, Andrew, MD, Ferrick, Kevin J., MD
Format: Artikel
Sprache:eng
Schlagworte:
African Americans
Aged
Aged, 80 and over
Algorithms
Atrial Fibrillation - diagnosis
Atrial Fibrillation - ethnology
Cardiac arrhythmia
Cardiovascular
Confidence intervals
Electrocardiography
Ethnicity
European Continental Ancestry Group
Female
Hispanic Americans
Humans
Inner city
Male
Middle Aged
Mortality
Population
Population Surveillance
Prevalence
Race
Retrospective Studies
Risk Assessment - methods
Risk Factors
Sinuses
United States - epidemiology
Variables
White people
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A risk score for atrial fibrillation (AF) has been developed by the Framingham Heart Study and Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)-AF consortium. However, validation of these risk scores in an inner-city population is uncertain. Thus, a validation model was built using the Framingham Risk Score for AF and CHARGE-AF covariates. An in and outpatient electrocardiographic database was interrogated from 2000 to 2013 for the development of AF. Patients were included if their age was >45 and
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2015.10.009